CompletedPhase 2

FST-100 in the Treatment of Acute Adenoviral Conjunctivitis

United States, India176 participantsStarted 2012-12-17

Plain-language summary

This randomized, double masked, multi-center study is being conducted to support the safety and efficacy of FST-100 for the treatment of acute adenoviral conjunctivitis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Have a clinical diagnosis of suspected acute adenoviral conjunctivitis in at least one eye. Exclusion Criteria: * Have a known sensitivity to any of the components of FST-100 or FST-100 vehicle.

What they're measuring

Adenoviral eradication and clinical resolution of the infection

Timeframe: 6-7 days

Trial details

NCT IDNCT01470664

SponsorShire

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2014-05-23

View on ClinicalTrials.gov More Acute Adenoviral Conjunctivitis trials